Cardlytics Capital Expenditures (CapEx) Growth & History (CDLX)
Cardlytics's capital expenditures (capex) was $480,000 for fiscal 2025.
View full Cardlytics company overviewCardlytics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $480,000 | −$1.1M | −69.27% |
| 2024 | 2024-12-31 | $1.6M | $895,000 | +134.18% |
| 2023 | 2023-12-31 | $667,000 | −$504,000 | −43.04% |
| 2022 | 2022-12-31 | $1.2M | −$1.9M | −62.32% |
| 2021 | 2021-12-31 | $3.1M | −$2.3M | −42.53% |
| 2020 | 2020-12-31 | $5.4M | −$2.9M | −34.66% |
| 2019 | 2019-12-31 | $8.3M | $2.4M | +39.81% |
| 2018 | 2018-12-31 | $5.9M | $4.7M | +387.24% |
| 2017 | 2017-12-31 | $1.2M | −$612,000 | −33.50% |
| 2016 | 2016-12-31 | $1.8M | — | — |
Cardlytics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2,000 | −$320,000 | −99.38% |
| Q1 2026 | 2026-03-31 | $28,000 | −$91,000 | −76.47% |
| Q4 2025 | 2025-12-31 | $25,000 | −$98,000 | −79.67% |
| Q3 2025 | 2025-09-30 | $14,000 | −$493,000 | −97.24% |
| Q2 2025 | 2025-06-30 | $322,000 | $41,000 | +14.59% |
| Q1 2025 | 2025-03-31 | $119,000 | −$532,000 | −81.72% |
| Q4 2024 | 2024-12-31 | $123,000 | −$151,000 | −55.11% |
| Q3 2024 | 2024-09-30 | $507,000 | $456,000 | +894.12% |
| Q2 2024 | 2024-06-30 | $281,000 | $263,000 | +1461.11% |
| Q1 2024 | 2024-03-31 | $651,000 | $291,000 | +80.83% |
| Q4 2023 | 2023-12-31 | $274,000 | $193,000 | +238.27% |
| Q3 2023 | 2023-09-30 | $51,000 | −$150,000 | −74.63% |
| Q2 2023 | 2023-06-30 | $18,000 | −$474,000 | −96.34% |
| Q1 2023 | 2023-03-31 | $360,000 | −$37,000 | −9.32% |
| Q4 2022 | 2022-12-31 | $81,000 | −$882,000 | −91.59% |
| Q3 2022 | 2022-09-30 | $201,000 | −$154,000 | −43.38% |
| Q2 2022 | 2022-06-30 | $492,000 | $79,000 | +19.13% |
| Q1 2022 | 2022-03-31 | $397,000 | −$980,000 | −71.17% |
| Q4 2021 | 2021-12-31 | $963,000 | −$1.8M | −64.56% |
| Q3 2021 | 2021-09-30 | $355,000 | −$1.1M | −75.78% |
| Q2 2021 | 2021-06-30 | $413,000 | −$320,000 | −43.66% |
| Q1 2021 | 2021-03-31 | $1.4M | $885,000 | +179.88% |
| Q4 2020 | 2020-12-31 | $2.7M | −$999,000 | −26.88% |
| Q3 2020 | 2020-09-30 | $1.5M | $924,000 | +170.48% |
| Q2 2020 | 2020-06-30 | $733,000 | −$1.8M | −70.99% |
| Q1 2020 | 2020-03-31 | $492,000 | −$1.0M | −67.02% |
| Q4 2019 | 2019-12-31 | $3.7M | $986,000 | +36.12% |
| Q3 2019 | 2019-09-30 | $542,000 | −$1.2M | −68.08% |
| Q2 2019 | 2019-06-30 | $2.5M | $1.5M | +135.29% |
| Q1 2019 | 2019-03-31 | $1.5M | $1.1M | +256.94% |
| Q4 2018 | 2018-12-31 | $2.7M | $2.5M | +1018.85% |
| Q3 2018 | 2018-09-30 | $1.7M | $1.2M | +251.55% |
| Q2 2018 | 2018-06-30 | $1.1M | $972,000 | +952.94% |
| Q1 2018 | 2018-03-31 | $418,000 | $32,000 | +8.29% |
| Q4 2017 | 2017-12-31 | $244,000 | — | — |
| Q3 2017 | 2017-09-30 | $483,000 | — | — |
| Q2 2017 | 2017-06-30 | $102,000 | — | — |
| Q1 2017 | 2017-03-31 | $386,000 | — | — |
Cardlytics capital expenditures (capex) trends
Over the last five fiscal years, Cardlytics's capital expenditures (capex) decreased from $5.4M to $480,000, a change of −$4.9M. The latest reported quarter, Q2 2026, shows $2,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardlytics source filings ↗